AN2 Therapeutics, Inc.
ANTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001880438
In the last 90 days, AN2 Therapeutics, Inc. insiders filed 1 open-market purchase and 5 sales; 66 institutions reported holding it in 13F filings for Q2 2026, worth $119.0M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in AN2 Therapeutics, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- −1 vs. Q1 2025
- Shares held
- 8.29M
- −6.06M (−42.2%) vs. Q1 2025
- Total value
- $8.78M
- −$10.7M (−55.0%) vs. Q1 2025
- New holders
- 8
- 9 more added
- Sold out
- 9
- 5 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ANTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 66 | $119.0M |
| Q1 2026 | 52 | $74.8M |
| Q4 2025 | 38 | $9.88M |
| Q3 2025 | 36 | $10.5M |
| Q2 2025 | 37 | $8.78M |
| Q1 2025 | 38 | $19.5M |
| Q4 2024 | 38 | $20.1M |
| Q3 2024 | 31 | $14.5M |
| Q2 2024 | 45 | $41.7M |
| Q1 2024 | 54 | $60.9M |
| Q4 2023 | 51 | $417.9M |
| Q3 2023 | 37 | $320.3M |
| Q2 2023 | 31 | $99.9M |
| Q1 2023 | 38 | $94.8M |
| Q4 2022 | 36 | $92.9M |
| Q3 2022 | 38 | $165.1M |
| Q2 2022 | 36 | $72.4M |
| Q1 2022 | 18 | $134.1M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding AN2 Therapeutics, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Almitas Capital LLC | 1,428,323 | $1.51M | 0.38% | +115,212+8.8% | Added |
| Vanguard Group Inc | 1,035,947 | $1.10M | 0.00% | 00.0% | Unchanged |
| Pfizer Inc | 715,295 | $758.2K | 0.13% | 00.0% | Unchanged |
| Peapod Lane Capital LLC | 582,770 | $617.8K | 0.62% | +1,917+0.3% | Added |
| Stonepine Capital Management, LLC | 544,494 | $577.2K | 0.57% | +544,494 | New |
| Landscape Capital Management, L.L.C. | 495,396 | $525.1K | 0.04% | +495,396 | New |
| Bank of Nova Scotia | 459,194 | $486.7K | 0.00% | 00.0% | Unchanged |
| Bank of Montreal | 422,077 | $447.4K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 398,854 | $422.8K | 0.00% | +30,146+8.2% | Added |
| Bank of America Corp | 385,511 | $408.6K | 0.00% | +280.0% | Added |
| BlackRock, Inc. | 319,295 | $338.5K | 0.00% | +18,609+6.2% | Added |
| Two Sigma Advisers, LP | 269,600 | $285.8K | 0.00% | −175,404−39.4% | Reduced |
| Geode Capital Management, LLC | 249,351 | $264.4K | 0.00% | −4,572−1.8% | Reduced |
| Two Sigma Investments, LP | 238,347 | $252.6K | 0.00% | −105,613−30.7% | Reduced |
| Morgan Stanley | 178,243 | $188.9K | 0.00% | +177,943+59,314.3% | Added |
| State Street Corp | 87,002 | $92.2K | 0.00% | 00.0% | Unchanged |
| Rangeley Capital, LLC | 65,000 | $68.9K | 0.09% | +15,000+30.0% | Added |
| UBS Group AG | 62,000 | $65.7K | 0.00% | −44,021−41.5% | Reduced |
| Bridgeway Capital Management, LLC | 59,900 | $63.5K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 45,320 | $48.0K | 0.00% | +45,320 | New |
| Northern Trust Corp | 43,196 | $45.8K | 0.00% | 00.0% | Unchanged |
| Captrust Financial Advisors | 40,000 | $42.4K | 0.00% | +30,000+300.0% | Added |
| XTX Topco Ltd | 26,044 | $27.6K | 0.00% | +26,044 | New |
| Integrated Wealth Concepts LLC | 25,000 | $26.5K | 0.00% | 00.0% | Unchanged |
| Private Advisor Group, LLC | 22,500 | $23.9K | 0.00% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 17,115 | $18.1K | 0.00% | −3,000−14.9% | Reduced |
| Citadel Advisors LLC | 12,497 | $13.2K | 0.00% | +12,497 | New |
| HRT Financial LP | 12,678 | $13.0K | 0.00% | +12,678 | New |
| Federated Hermes, Inc. | 12,237 | $13.0K | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 10,184 | $10.8K | 0.00% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 10,062 | $10.7K | 0.00% | +10,062 | New |
| Tower Research Capital LLC (TRC) | 5,313 | $5.63K | 0.00% | +3,231+155.2% | Added |
| Highline Wealth Partners LLC | 5,000 | $5.30K | 0.00% | +5,000 | New |
| Innovative Advisory Group, LLC | 1,170 | $1.24K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 312 | $331 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 300 | $318 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 200 | $212 | 0.00% | 00.0% | Unchanged |
| BML Capital Management, LLC | 0 | $0 | 0.00% | −5,749,432−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −1,000,000−100.0% | Sold out |
| Aldebaran Capital, LLC | 0 | $0 | 0.00% | −406,623−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −50,038−100.0% | Sold out |
| Lepercq De Neuflize Asset Management LLC | 0 | $0 | 0.00% | −23,234−100.0% | Sold out |
| Inspirion Wealth Advisors, LLC | 0 | $0 | 0.00% | −18,950−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −18,131−100.0% | Sold out |
| Coldstream Capital Management Inc | 0 | $0 | 0.00% | −783−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −49−100.0% | Sold out |